cotellic
roche registration gmbh - cobimetinib hemifumarát - melanóma - daganatellenes szerek - cotellic, vemurafenib, braf v600 mutáció inoperábilis vagy áttétes melanoma felnőtt betegek kezelésére javallott együttes használatra.
brufen 200 mg filmtabletta
viatris healthcare ltd. - ibuprofen -
brufen 400 mg filmtabletta
viatris healthcare ltd. - ibuprofen -
mektovi
pierre fabre medicament - binimetinib - melanóma - daganatellenes szerek - binimetinib kombinálva encorafenib kezelésére javallt felnőtt betegek inoperábilis vagy áttétes melanoma a braf mutáció v600.
tagrisso
astrazeneca ab - osimertinib mesilate - karcinóma, nem kissejtes tüdő - egyéb daganatellenes szerek, a protein kináz inhibitorok - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - daganatellenes szerek - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - daganatellenes szerek - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
itraconazol-ratiopharm 100 mg kemény kapszula
teva gyógyszergyár zrt. - itrakonazol -
orungal 100 mg kemény kapszula
janssen-cilag kft. - itrakonazol -
voriconazole fresenius kabi 200 mg por oldatos infúzióhoz
fresenius kabi hungary kft. - vorikonazol -